BayBio Notes
<< < 8 9 10 11 12 20 30 100 > >>
- Pleasanton's IntegenX buys GE subsidiary - Apr 23, 2012
IntegenX Inc. will buy a wholly owned subsidiary of GE Healthcare Bio-Sciences, a move that the Pleasanton-based company said will help its DNA identification system get to market sooner....
Read More... - Upcoming Life Science Business Development Course Returns to UC Berkeley Extension - Apr 23, 2012
Hi, I wanted to be sure that you were aware that Life Science Business Development (formerly called Biotechnology Business Development) will be taught again by the original faculty at UC Berkeley...
Read More... - BioTime and its Subsidiary OrthoCyte Corporation Provides Update on Preclinical Development of OTX-CP07 - Apr 23, 2012
ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE Amex: BTX) announced today that BioTime’s CEO Michael West, Ph.D. will provide and update the development of OTX-CP07 by BioTime’s...
Read More... - BioTime’s Subsidiary ReCyte Therapeutics, Inc. Provides Update on Preclinical Development of Vascular Progenitors for the Treatment of Age-Related Vascular Disease - Apr 23, 2012
ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE Amex: BTX) announced today that Steven Kessler, Ph.D., Vice President of Research at BioTime’s subsidiary ReCyte Therapeutics, Inc. will...
Read More... - BioTime’s Subsidiary OncoCyte Corporation Provides Update on PanC-DxTM, and Related Diagnostic Products - Apr 23, 2012
ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE Amex: BTX) announced today that Joseph Wagner, Ph.D., the CEO of BioTime’s subsidiary OncoCyte Corporation and Karen B. Chapman, Ph.D.,...
Read More... - BioTime’s Subsidiary Cell Cure Neurosciences, Ltd. Provides Update on OpRegen® Product Development - Apr 23, 2012
ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE Amex: BTX) announced today that Charles S. Irving, Ph.D., the CEO of BioTime’s subsidiary Cell Cure Neurosciences, Ltd. will provide an...
Read More... - BioTime Provides Update on ReneviaTM Product Development - Apr 23, 2012
ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE Amex:BTX) announced today that William Tew, Ph.D., BioTime’s Chief Commercial Officer will provide an update on the development of ReneviaTM...
Read More... - Landec Corporation Acquires GreenLine Foods, Inc. - Apr 23, 2012
MENLO PARK, Calif.--(BUSINESS WIRE)--Landec Corporation (Nasdaq:LNDC), a company that develops and markets patented products for food, agricultural and biomedical applications, announced today that...
Read More... - Brain Surgery for Epilepsy Underutilized - Apr 23, 2012
Ten years ago, a landmark clinical trial in Canada demonstrated the unequivocal effectiveness of brain surgeries for treating uncontrolled epilepsy, but since then the procedure has not been widely...
Read More... - Medgenics Files for U.S. Orphan Drug Designation for INFRADURE for the Treatment of Hepatitis D - Apr 23, 2012
MISGAV, Israel & SAN FRANCISCO--(BUSINESS WIRE)--Medgenics, Inc. (NYSE Amex: MDGN and AIM: MEDU, MEDG), the developer of a novel technology for the sustained production and delivery of...
Read More... - City Project Continues to Repave Parnassus Avenue - Apr 23, 2012
The City of San Francisco's project to repave and make other upgrades on Parnassus Avenue has had a few delays due to rain, but the project is progressing and starting to move on to the main...
Read More... - BioTime Demonstrates Efficient Method for the Manufacture of Cartilage-Producing Cells from Human Embryonic Stem Cells - Apr 23, 2012
ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE Amex: BTX) and its wholly owned subsidiary OrthoCyte Corporation reported today a means of manufacturing cartilage from human embryonic stem...
Read More... - SeptRx® completes enrollment for its “InterSEPT” CE mark trial, partners with CoRRect Medical GmbH for European distribution of its SeptRx® Intrapocket PFO Occluder (IPO) - Apr 23, 2012
FREMONT, Calif.--(BUSINESS WIRE)--SeptRx® completes enrollment for its “InterSEPT” CE mark trial, partners with CoRRect Medical GmbH for European distribution of its SeptRx® Intrapocket PFO...
Read More... - InSite Vision to Report First Quarter 2012 Financial Results on May 1, 2012 - Apr 23, 2012
ALAMEDA, Calif.--(BUSINESS WIRE)--InSite Vision Incorporated (OTCBB: INSV) announced today that it will report financial results for the first quarter ended March 31, 2012 on Tuesday, May 1, 2012....
Read More... - NextBio Clinical Extends Life Sciences Platform From the Bench to Translational Medicine - Apr 23, 2012
SANTA CLARA, Calif.--(BUSINESS WIRE)--NextBio Clinical extends the NextBio research platform from the bench to translational medicine and biomarker discovery, correlating patient clinical and...
Read More... - IntegenX Acquires DNA Consumable Portfolio From GE Healthcare - Apr 23, 2012
PLEASANTON, Calif.--(BUSINESS WIRE)--IntegenX Inc. today announced that it has acquired an IP portfolio of DNA consumables from GE Healthcare Bio-Sciences for its rapid human identification system.
Read More... - Natus Medical to Hold Conference Call on April 23 - Apr 23, 2012
SAN CARLOS, Calif.--(BUSINESS WIRE)--Natus Medical Incorporated (NASDAQ:BABY) today announced that Natus management will host an investment-community conference call this morning, Monday, April 23,...
Read More... - Media Advisory: UCSF Announces $100 Million Education Fundraising Initiative to Offset State Cuts - Apr 23, 2012
UCSF Chancellor Sue Desmond-Hellman, MD, MPH will introduce a four-year, $100 million education fundraising initiative during a commencement address on April 24. This campus-wide goal includes $80...
Read More... - What Are the Hottest Targets in Biotech Today? - Apr 23, 2012
Read More... - The Quality of Your Life is All About Relationships plus Jobs and Events - Apr 23, 2012
Here’s another week of great opportunities to network with professionals while you’re continuing to learn about topics of great value in improving your skills in your work advancing your...
Read More...
